Associate Director, US Consumer Hematology Marketing

Associate Director, US Consumer Hematology Marketing

Date of Posting:
Jan 5, 2026

Business Area:
Sales & Marketing

Job Type: Direct Employee

Territory:

Full-Time or Part-Time:
Full Time

Seniority:
Mid-senior

With its beginnings in a family run pharmacy in Correggio, Italy in the 1920s, Recordati is now a global pharmaceutical company, listed on the Italian stock exchange, with over 4,500 employees and turnover of over Euro 2bn. We are a group of like-minded, passionate individuals who go to extraordinary lengths for our patients, customers, partners, investors and the people across the globe who we serve.

We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries. At Recordati, our mantra is simple. We’ve always believed that health, and the opportunity to live life to the fullest, is a right, not a privilege. Whether that is for common diseases or the rarest – we want to give people the opportunity to be the best version of themselves.

This drive will never stop. Together, we will always be reimagining tomorrow – with new ideas, new technologies and new innovations to fight diseases. Recordati. Unlocking the full potential of life.

Recordati Rare Diseases, Inc. (RRD) develops high-impact therapies for rare diseases, focusing on providing treatments to underserved communities in the U.S. Our mission is to mitigate the impact of rare diseases through increased awareness, better diagnoses, and improved treatment access in endocrinology, metabolic, hematology and oncology franchises. RRD is dedicated to fostering a dynamic work environment that promotes professional growth and a significant impact on patients' lives.

• Reports To:
  
  Senior Director, Hematology Marketing
• Direct Report(s):
  None
• Areas Managed:
  Hematology Marketing

The Associate Director, U.S. Consumer Hematology Marketing will lead consumer marketing strategy and tactics, contributing to the ongoing launch of ENJAYMO (sutimlimab) – a first-in-class product. This individual will be responsible for the development and execution of innovative marketing strategies and tactics for patients. The individual should have experience working in a nimble, cross-functional environment, as they will work closely with patient support services, patient advocacy, medical, legal and regulatory.

This position requires a highly motivated individual who can work effectively in a dynamic environment with a high degree of autonomy and creative problem-solving skills.

The development of short/ mid/ and long-term strategies, annual brand plans, tactical execution and related activities in rare disease is complex, challenging, and ever-changing. As such, the Associate Director of U.S. Consumer Marketing requires scientific acumen, strong knowledge and application of marketing disciplines, as well as effective leadership skills to ensure collaboration, effective decision-making, and clear guidance to meet financial targets & other objectives with seamless execution.

• Lead consumer marketing strategy for ENJAYMO (sutimlimab) in the U.S.
• Lead the development, creation, and implementation of innovative consumer promotional materials.
• Lead and contribute to unbranded disease education materials for patients.
• Lead digital strategy and content development for consumers across channels – e.g., paid search, paid social, and display. Monitor performance and make recommendations based on trends and investment analyses.
• Make significant contributions to the ENJAYMO (sutimlimab) brand plan and lead development of the tactical plan for patient engagement.
• Gather insights to inform consumer strategy and execution through leadership of patient advisory engagements and partnership with market research vendors.
• Demonstrate deep knowledge of disease and market trends.
• Manage marketing agencies to foster a positive working relationship, to ensure high-quality materials are prepared for internal review by the Promotional Review Committee (PRC)…